| 1 |
32416700 | Benzophenone Sulfonamide Derivatives as Interacting Partners and Inhibitors of Human P-glycoprotein. | 2020 |
1 |
| 2 |
31479713 | Modulation of hepatic ABC transporters by Eruca vesicaria intake: Potential diet-drug interactions. | 2019 Nov |
1 |
| 3 |
28935591 | Evidence That P-glycoprotein Inhibitor (Elacridar)-Loaded Nanocarriers Improve Epidermal Targeting of an Anticancer Drug via Absorptive Cutaneous Transporters Inhibition. | 2018 Feb |
1 |
| 4 |
29683403 | Paracellular tightness and the functional expression of efflux transporters P-gp and BCRP in bEnd3 cells. | 2018 Aug |
1 |
| 5 |
29704642 | Verapamil and riluzole cocktail liposomes overcome pharmacoresistance by inhibiting P-glycoprotein in brain endothelial and astrocyte cells: A potent approach to treat amyotrophic lateral sclerosis. | 2018 Jul 30 |
3 |
| 6 |
29986516 | Detection of the Mitochondrial Membrane Potential by the Cationic Dye JC-1 in L1210 Cells with Massive Overexpression of the Plasma Membrane ABCB1 Drug Transporter. | 2018 Jul 7 |
1 |
| 7 |
27996361 | Insight into the molecular mechanism of P-glycoprotein mediated drug toxicity induced by bioflavonoids: an integrated computational approach. | 2017 May |
2 |
| 8 |
29326490 | Investigation of in vitro absorption, distribution, metabolism, and excretion and in vivo pharmacokinetics of paromomycin: Influence on oral bioavailability. | 2017 Jul-Aug |
4 |
| 9 |
26058994 | Drug-Drug Interactions of a Novel κ-Opioid Receptor Agonist, Nalfurafine Hydrochloride, Involving the P-Glycoprotein. | 2016 Oct |
1 |
| 10 |
26507673 | Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier. | 2016 Feb |
2 |
| 11 |
25661387 | Soluplus(®) micelles as a potential drug delivery system for reversal of resistant tumor. | 2015 Feb |
2 |
| 12 |
26228278 | Reversal of P-glycoprotein overexpression by Ginkgo biloba extract in the brains of pentylenetetrazole-kindled and phenytoin-treated mice. | 2015 Aug |
1 |
| 13 |
26548081 | Interaction of mouse intestinal P-glycoprotein with oral antidiabetic drugs and its inhibitors. | 2015 Sep |
1 |
| 14 |
24280122 | The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram. | 2014 Mar 15 |
1 |
| 15 |
24366438 | Role of P-glycoprotein in regulating cilnidipine distribution to intact and ischemic brain. | 2014 |
1 |
| 16 |
24780744 | In vivo anticancer synergy mechanism of doxorubicin and verapamil combination treatment is impaired in BALB/c mice with metastatic breast cancer. | 2014 Aug |
1 |
| 17 |
24867970 | In vitro and in vivo evidence for amphotericin B as a P-glycoprotein substrate on the blood-brain barrier. | 2014 Aug |
1 |
| 18 |
25030439 | Effect of 9-cis retinoic acid and all-trans retinoic acid in combination with verapamil on P-glycoprotein expression in L1210 cells. | 2014 |
5 |
| 19 |
25048967 | Characterization of Lin⁻ALDH (bright) population using Ehrlich ascites tumor cells in mice. | 2014 Oct |
1 |
| 20 |
25061162 | Pharmacoproteomics-based reconstruction of in vivo P-glycoprotein function at blood-brain barrier and brain distribution of substrate verapamil in pentylenetetrazole-kindled epilepsy, spontaneous epilepsy, and phenytoin treatment models. | 2014 Oct |
5 |
| 21 |
22504657 | Suppression of intestinal polyp development in Apc(Min/+) mice through inhibition of P-glycoprotein using verapamil. | 2013 Jan |
2 |
| 22 |
23395915 | Effect of repeated dosing on rifampin exposure in BALB/c mice. | 2013 Apr 11 |
2 |
| 23 |
23845421 | (R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP. | 2013 Oct |
3 |
| 24 |
22264856 | Evaluation of the relationship between [18F]FDG and P-glycoprotein expression: an experimental study. | 2012 Jul |
2 |
| 25 |
22372629 | Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique. | 2012 Mar |
2 |
| 26 |
22615365 | Heat shock factor-1 knockout induces multidrug resistance gene, MDR1b, and enhances P-glycoprotein (ABCB1)-based drug extrusion in the heart. | 2012 Jun 5 |
1 |
| 27 |
21350189 | Upregulation of P-glycoprotein by probiotics in intestinal epithelial cells and in the dextran sulfate sodium model of colitis in mice. | 2011 Jun |
1 |
| 28 |
21934030 | Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate. | 2011 Dec |
1 |
| 29 |
20460505 | The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature. | 2010 Jun 1 |
2 |
| 30 |
20603190 | Preservation of transendothelial glucose transporter 1 and P-glycoprotein transporters in a cortical slice culture model of the blood-brain barrier. | 2010 Sep 29 |
1 |
| 31 |
19291858 | Pretreatment with R(+)-verapamil significantly reduces mortality and cytokine expression in murine model of septic shock. | 2009 Apr |
2 |
| 32 |
19523457 | Regional differences in capillary density, perfusion rate, and P-glycoprotein activity: a quantitative analysis of regional drug exposure in the brain. | 2009 Oct 15 |
1 |
| 33 |
19584540 | Inhibition of P-glycoprotein enhances the suppressive effect of kaempferol on transformation of the aryl hydrocarbon receptor. | 2009 Jul |
2 |
| 34 |
19807929 | The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors. | 2009 Oct 6 |
2 |
| 35 |
20097962 | Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein-mediated drug efflux activity. | 2009 Dec |
1 |
| 36 |
17920233 | Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity. | 2008 Feb |
5 |
| 37 |
18849167 | Chalcogenopyrylium dyes as inhibitors/modulators of P-glycoprotein in multidrug-resistant cells. | 2008 Nov 15 |
1 |
| 38 |
19356011 | Verapamil, but not probenecid, co-administration can convert desloratadine to a sedating antihistamine in mice. | 2007 Jan |
1 |
| 39 |
16465381 | Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors. | 2006 Mar |
2 |
| 40 |
16841511 | The influence of P-glycoprotein on cerebral and hepatic concentrations of nortriptyline and its metabolites. | 2006 |
1 |
| 41 |
16858128 | What kinds of substrates show P-glycoprotein-dependent intestinal absorption? Comparison of verapamil with vinblastine. | 2006 Jun |
1 |
| 42 |
16962737 | L1210 cells cultivated under the selection pressure of doxorubicin or vincristine express common mechanisms of multidrug resistance based on the overexpression of P-glycoprotein. | 2006 Dec |
1 |
| 43 |
21783720 | Pesticides and their binary combinations as P-glycoprotein inhibitors in NIH 3T3/MDR1 cells. | 2006 Nov |
1 |
| 44 |
15771234 | Functional evidence for P-glycoprotein at the nose-brain barrier. | 2005 Jan |
1 |
| 45 |
15783071 | Pharmacokinetics of substrate uptake and distribution in murine brain after nasal instillation. | 2005 Feb |
4 |
| 46 |
15835751 | Isolated rafts from adriamycin-resistant P388 cells contain functional ATPases and provide an easy test system for P-glycoprotein-related activities. | 2005 Mar |
1 |
| 47 |
15176436 | Uptake and efflux of quinacrine, a candidate for the treatment of prion diseases, at the blood-brain barrier. | 2004 Apr |
1 |
| 48 |
15322237 | P-glycoprotein mediates resistance to histidine kinase inhibitors. | 2004 Sep |
1 |
| 49 |
15359572 | In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood-brain barrier. | 2004 Aug |
1 |
| 50 |
15638123 | Functional fluo-3/AM assay on P-glycoprotein transport activity in L1210/VCR cells by confocal microscopy. | 2004 Sep |
2 |